Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 91.67B | 89.45B | 79.74B | 79.71B | 72.85B | 58.38B |
Gross Profit | 47.17B | 45.84B | 40.45B | 39.29B | 37.19B | 31.31B |
EBITDA | 27.06B | 26.72B | 23.46B | 23.08B | 22.87B | 20.77B |
Net Income | 14.43B | 14.44B | 14.50B | 14.46B | 12.67B | 11.38B |
Balance Sheet | ||||||
Total Assets | 147.30B | 162.51B | 132.64B | 137.96B | 138.60B | 125.20B |
Cash, Cash Equivalents and Short-Term Investments | 20.31B | 29.84B | 16.34B | 15.38B | 18.54B | 18.79B |
Total Debt | 3.22B | 3.45B | 3.50B | 3.85B | 3.10B | 4.79B |
Total Liabilities | 51.82B | 62.93B | 52.50B | 54.63B | 54.58B | 50.05B |
Stockholders Equity | 94.53B | 98.64B | 78.97B | 81.96B | 82.64B | 73.82B |
Cash Flow | ||||||
Free Cash Flow | 22.02B | 21.35B | 18.71B | 14.11B | 15.22B | 14.16B |
Operating Cash Flow | 26.58B | 26.10B | 24.71B | 20.64B | 22.90B | 18.86B |
Investing Cash Flow | -4.47B | -5.46B | -5.77B | -5.00B | -7.73B | -6.80B |
Financing Cash Flow | -16.88B | -10.35B | -16.12B | -16.34B | -16.04B | -8.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $136.61B | 23.43 | 7.31% | 1.53% | 0.64% | 10.02% | |
78 Outperform | $37.82B | 14.53 | 15.09% | 3.71% | 1.25% | -13.02% | |
73 Outperform | $21.05B | 21.22 | 9.84% | 1.79% | -0.37% | 44.52% | |
71 Outperform | $2.42B | 13.68 | 11.33% | 3.35% | 6.18% | 61.39% | |
65 Neutral | $9.64B | 9.54 | 7.90% | 3.96% | -5.17% | -0.74% | |
65 Neutral | $26.91B | 15.06 | -4.01% | 3.23% | 1.02% | 2.11% | |
61 Neutral | $28.54B | 49.10 | -0.98% | 2.53% | 2.47% | -105.09% |